Physician profile
Stephen Saenz
NPI 1043742059
$1,245.48
in general payments reported to CMS, 2019-2025
9 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.92 · 2021: $173 · 2022: $364 · 2023: $78.33 · 2024: $343 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $437.23 | 2022-2025 | |
| Bioventus LLC | $256.18 | 2020-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $133.56 | 2022 | |
| Fidia Pharma USA INC. | $119.62 | 2021 | |
| Depuy Synthes Sales INC. | $105.09 | 2022-2023 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $95.19 | 2021-2025 | Iovera, Zilretta, Exparel |
| Mission Medical Distribution, LLC | $57.25 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.04 | 2024 | |
| Pacira Therapeutics, INC. | $17.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Saenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.